Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed Fallopian Tube Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00189553
What this trial is testing

Caelyx Plus Carboplatin Versus Paclitaxel Plus Carboplatin in Patients With Epithelial Ovarian Cancer in Late Relapse

Who this might be right for
Ovarian CancerFallopian Tube Cancer
ARCAGY/ GINECO GROUP 976
Testing effectiveness (Phase 2)WithdrawnNCT01766622
What this trial is testing

18F-CP18 Imaging Studies for Cancer Treatment With Birinapant

Who this might be right for
Ovarian NeoplasmsOvarian CancerFallopian Tube Neoplasms+1 more
National Institutes of Health Clinical Center (CC)
Early research (Phase 1)Study completedNCT00431054
What this trial is testing

Perifosine and Docetaxel in Patients With Relapsed Epithelial Ovarian Cancer

Who this might be right for
Ovarian Cancer
M.D. Anderson Cancer Center 22
Testing effectiveness (Phase 2)Study completedNCT00517621
What this trial is testing

Use of FACT-GOG/NTX Questionnaire in Peripheral Neurotoxicity & Validation of a French Version of This Questionnaire

Who this might be right for
Ovarian CancerFallopian Tube CancerPeritoneal Neoplasms
ARCAGY/ GINECO GROUP 100
Large-scale testing (Phase 3)Study completedNCT00002895
What this trial is testing

Early Chemotherapy Based on CA 125 Level Alone Compared With Delayed Chemotherapy in Treating Patients With Recurrent Ovarian Epithelial , Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
Medical Research Council 1,400
Large-scale testing (Phase 3)Study completedNCT02855944
What this trial is testing

ARIEL4: A Study of Rucaparib Versus Chemotherapy BRCA Mutant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients

Who this might be right for
Ovarian CancerEpithelial Ovarian CancerFallopian Tube Cancer+1 more
pharmaand GmbH 349
Large-scale testing (Phase 3)Not Yet RecruitingNCT07816666
What this trial is testing

Torvutatug Samrotecan With or Without Bevacizumab as Maintenance Treatment of Platinum-sensitive Relapsed Epithelial Ovarian Cancer

Who this might be right for
Platinum-sensitive Relapsed Epithelial Ovarian CancerPlatinum-sensitive Relapsed Fallopian Tube CancerPlatinum-sensitive Relapsed Primary Peritoneal Cancer
AstraZeneca 600
Not applicableStudy completedNCT00086567
What this trial is testing

Predictors of Relapse of Ovarian, Peritoneal, and Fallopian Tube Cancers

Who this might be right for
Fallopian Tube CancerPeritoneal NeoplasmsEpithelial Ovarian Cancer
National Cancer Institute (NCI) 119
Testing effectiveness (Phase 2)Study completedNCT01891344
What this trial is testing

Rucaparib in Patients With Platinum-Sensitive, Relapsed, High-Grade Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (ARIEL2)

Who this might be right for
Ovarian CancerEpithelial Ovarian CancerFallopian Tube Cancer+1 more
pharmaand GmbH 491
Testing effectiveness (Phase 2)Study completedNCT03345485
What this trial is testing

Study of the Safety, Pharmacokinetics and Efficacy of Tinostamustine in Patients With Advanced Solid Tumors.

Who this might be right for
Small Cell Lung CancerSoft Tissue SarcomaTriple-negative Breast Cancer+2 more
Mundipharma Research Limited 71
Testing effectiveness (Phase 2)Study completedNCT02283658
What this trial is testing

Everolimus and Letrozole in Treating Patients With Recurrent Hormone Receptor Positive Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer

Who this might be right for
Ovarian Endometrioid AdenocarcinomaOvarian Seromucinous CarcinomaOvarian Serous Cystadenocarcinoma+6 more
Mayo Clinic 20
Not applicableLooking for participantsNCT05236686
What this trial is testing

Survival Effect of Hepato-celiac Lymphadenectomy In Primary or Relapsed Ovarian Cancer

Who this might be right for
Epithelial Ovarian CancerFallopian Tube CancerPrimary Peritoneal Carcinoma
Shanghai Gynecologic Oncology Group 94
Early research (Phase 1)Ended earlyNCT01329549
What this trial is testing

Dose Escalation Study of BIBF 1120 in Combination With Carboplatin and PLD in Relapsed Ovarian Cancer (OC)

Who this might be right for
Ovarian Neoplasms
Boehringer Ingelheim 2
Testing effectiveness (Phase 2)Active Not RecruitingNCT01012817
What this trial is testing

Veliparib and Topotecan Hydrochloride in Treating Patients With Solid Tumors, Relapsed or Refractory Ovarian Cancer, or Primary Peritoneal Cancer

Who this might be right for
Metastatic Malignant Solid NeoplasmRecurrent Fallopian Tube CarcinomaRecurrent Ovarian Carcinoma+2 more
National Cancer Institute (NCI) 88
Testing effectiveness (Phase 2)Ended earlyNCT01137071
What this trial is testing

Consolidation Therapy With Hu3S193 for Women With Ovarian, Primary Peritoneal or Fallopian Tube Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPeritoneal Cavity Cancer
Recepta Biopharma 29
Testing effectiveness (Phase 2)Study completedNCT00189566
What this trial is testing

Taxol® in Monotherapy or in Combination With Topotecan or Carboplatin in Patients With Epithelial Ovarian Cancer in Early Relapse

Who this might be right for
Ovarian CancerFallopian Tube CancerMalignant Tumor of Peritoneum
ARCAGY/ GINECO GROUP 165
Early research (Phase 1)Study completedNCT01940172
What this trial is testing

Study of Birinapant in Combination With Conatumumab in Subjects With Relapsed Ovarian Cancer

Who this might be right for
Relapsed Epithelial Ovarian CancerRelapsed Primary Peritoneal CancerRelapsed Fallopian Tube Cancer
TetraLogic Pharmaceuticals 27
Testing effectiveness (Phase 2)Study completedNCT03657966
What this trial is testing

DCVAC/OvCa After Standard-of-care Chemotherapy in Women With Relapse of Platinum-sensitive Epithelial Ovarian Cancer

Who this might be right for
Ovarian Cancer Recurrent
SOTIO a.s. 33
Large-scale testing (Phase 3)Study completedNCT01968213
What this trial is testing

Phase 3 Study of Rucaparib as Switch Maintenance After Platinum in Relapsed High Grade Serous or Endometrioid Ovarian Cancer (ARIEL3)

Who this might be right for
Ovarian CancerFallopian Tube CancerPeritoneal Cancer
pharmaand GmbH 564
Testing effectiveness (Phase 2)Study completedNCT02657928
What this trial is testing

Ribociclib and Letrozole in Treating Patients With Relapsed ER Positive Ovarian, Fallopian Tube, Primary Peritoneal, or Endometrial Cancer

Who this might be right for
Estrogen Receptor PositivePostmenopausalRecurrent Fallopian Tube Carcinoma+3 more
Mayo Clinic 40
Next Page